United Kingdom to India: Syringe Import Trade Route

The United Kingdom to India Syringe corridor is one of India's established pharmaceutical import routes from United Kingdom, with 49 shipments documented worth a combined $1.4M USD. The route is dominated by M/S. ASTRAZENECA UK LTD.,, which alone accounts for roughly 24% of all import value, reflecting the consolidated nature of United Kingdom's syringe export sector.

Across 18 active United Kingdom suppliers, the average shipment value stands at $28.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 31.1%, placing it at rank #8 among India's top syringe import origins globally.

On the Indian buyer side, key Indian importers include ASTRAZENECA PHARMA INDIA LIMITED, DR.REDDY'S LABORATORIES LTD, FISHER BIOPHARMA SERVICES INDIA PVT LTD and 9 others. ASTRAZENECA PHARMA INDIA LIMITED is the single largest Indian importer with 2 shipments valued at $334.7K USD.

India's syringe imports from United Kingdom are driven primarily by a handful of large-scale United Kingdom manufacturers. M/S. ASTRAZENECA UK LTD., with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — Indian buyers benefit from United Kingdom supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — M/S. ASTRAZENECA UK LTD.,, ALMAC CLINICAL SERVICES, FlsherClinical Services — together account for 68% of total trade value on this route. The average shipment value of $28.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as pf-06741086 150 mg/ml solution for injection 0.5ml pre-filled syringe pfs 10 pfs in carton 10 cartons x 10 pfs = tota and labelled carton containingorencia 125/mgml liquid for solution in prefilled syringe(abatacept)(drl_ab) (drlab-653 nos)labelled carton containing (drl-ab)(abatacept)orencia 125/m, suggesting that Indian buyers tend to consolidate orders across related product lines from the same United Kingdom supplier.

On the buying side, ASTRAZENECA PHARMA INDIA LIMITED is the largest importer with 2 shipments worth $334.7K USD — representing 24% of all syringe imports from United Kingdom on this route. A total of 12 buyers are active on this corridor.